TRAF2 is Upregulated in Relapsing-Remitting Multiple Sclerosis

Publisher： Karger

E-ISSN： 1423-0216|20|3|177-183

ISSN： 1021-7401

Source： Neuroimmunomodulation, Vol.20, Iss.3, 2013-04, pp. : 177-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FADD Is Upregulated in Relapsing Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 21, Iss. 5, 2014-03 ,pp. : 221-225

Karger

Access to resources Recommend Favorite

CCL5, CXCL10 and CXCL11 Chemokines in Patients with Active and Stable Relapsing-Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 18, Iss. 1, 2010-08 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease

By  

Neuroimmunomodulation, Vol. 23, Iss. 1, 2015-11 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

Severe Disability in Patients with Relapsing-Remitting Multiple Sclerosis Is Associated with Profound Changes in the Regulation of Leptin Secretion

By  

Neuroimmunomodulation, Vol. 20, Iss. 6, 2013-08 ,pp. : 341-347

Karger

Access to resources Recommend Favorite

Interferon β-1a Induces Tumor Necrosis Factor Receptor 1 but Decreases Tumor Necrosis Factor Receptor 2 Leukocyte mRNA Levels in Relapsing-Remitting Multiple Sclerosis

By  

Neuroimmunomodulation, Vol. 16, Iss. 3, 2009-02 ,pp. : 171-176

Karger

Access to resources Recommend Favorite